Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Norwegian University of Science and Technology
With
St. Olavs Hospital
It has been shown that low dose acetylsalicylic acid (ASA) in pregnancy reduces adverse outcome of pregnancy in women that have high risk of developing preeclampsia (PE). It is a challenge for the clinician to identify the high risk women. Doppler blood flow measurements in uterine arteries in second trimester have been shown useful to predict the development of the disease but prophylactic treatment with ASA from this point in pregnancy has not been proven effective. Fetal Medical Foundation has developed an algorithm that calculates individual risks for PE/ PIH based on Doppler blood flow measurements and anamnestic information.
Age
18–60
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Pregnant
Nulliparous
Para 1+ with previous preeclampsia or gestational hypertension
last menstrual period (LMP) pregnancy length at inclusion \< 13 weeks
Residence in Trondheim + 8 surrounding municipalities
